EE119 Development of a De Novo Model to Assess the Cost-Effectiveness of a New Treatment Option for Patients With Primary Immunoglobulin a Nephropathy (IgAN)

Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.389
https://www.valueinhealthjournal.com/article/S1098-3015(23)03519-2/fulltext
Title : EE119 Development of a De Novo Model to Assess the Cost-Effectiveness of a New Treatment Option for Patients With Primary Immunoglobulin a Nephropathy (IgAN)
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03519-2&doi=10.1016/j.jval.2023.09.389
First page :
Section Title :
Open access? : No
Section Order : 12413
Categories :
Tags :
Regions :
ViH Article Tags :